(VNDA) Vanda Pharmaceuticals - Performance -14.3% in 12m
VNDA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-73.23%
#106 in Peer-Group
Rel. Strength
27.30%
#5400 in Stock-Universe
Total Return 12m
-14.34%
#73 in Peer-Group
Total Return 5y
-57.40%
#70 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 30.3 |
| High / Low | USD |
|---|---|
| 52 Week High | 6.34 USD |
| 52 Week Low | 3.92 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 84.11 |
| Buy/Sell Signal +-5 | -0.73 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VNDA (-14.3%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: VNDA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VNDA
| Total Return (including Dividends) | VNDA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 8.88% | 3.18% | 4.55% |
| 3 Months | 4.14% | 2.36% | 10.78% |
| 12 Months | -14.34% | -10.75% | 14.71% |
| 5 Years | -57.40% | -24.51% | 112.53% |
| Trend Score (consistency of price movement) | VNDA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 62.4% | 18.8% | 79.2% |
| 3 Months | 49.7% | 71.5% | 92.9% |
| 12 Months | -75% | -84.3% | 44.2% |
| 5 Years | -85.2% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th71.00 | 5.53% | 4.17% |
| 3 Month | %th52.50 | 1.73% | -5.54% |
| 12 Month | %th64.00 | -4.02% | -24.96% |
| 5 Years | %th66.00 | -43.57% | -80.36% |
FAQs
Does Vanda Pharmaceuticals (VNDA) outperform the market?
No,
over the last 12 months VNDA made -14.34%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months VNDA made 4.14%, while XBI made 2.36%.
Performance Comparison VNDA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VNDA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4% | 4.3% | -6.1% | -29% |
| US NASDAQ 100 | QQQ | 3.9% | 3.4% | -6.6% | -29% |
| German DAX 40 | DAX | 3.7% | 8.5% | -20.3% | -45% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.3% | 4.7% | -4% | -32% |
| Hongkong Hang Seng | HSI | 4.4% | 3.1% | -21.8% | -50% |
| India NIFTY 50 | INDA | 4.1% | 6.6% | -6.1% | -14% |
| Brasil Bovespa | EWZ | 2.6% | 1.1% | -30.6% | -28% |
VNDA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 3.3% | 2% | -11.5% | -42% |
| Consumer Discretionary | XLY | 5% | 7% | 2.8% | -35% |
| Consumer Staples | XLP | 8% | 10.1% | -4% | -23% |
| Energy | XLE | 7.8% | 4.3% | -2.5% | -11% |
| Financial | XLF | 4.7% | 6.4% | -8.3% | -42% |
| Health Care | XLV | 5.6% | 7.2% | 1.6% | -8% |
| Industrial | XLI | 4.9% | 5.7% | -12% | -38% |
| Materials | XLB | 5.9% | 6.6% | -5.9% | -17% |
| Real Estate | XLRE | 9.2% | 9.4% | -3.5% | -26% |
| Technology | XLK | 3.7% | 0.4% | -7.3% | -25% |
| Utilities | XLU | 6.8% | 7.9% | -8.9% | -38% |
| Aerospace & Defense | XAR | 2.6% | -0.7% | -26.3% | -66% |
| Biotech | XBI | 6% | 5.7% | 7.6% | -4% |
| Homebuilder | XHB | 5.9% | 5% | 5.3% | -15% |
| Retail | XRT | 6.7% | 6.8% | 2.3% | -21% |
VNDA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 11% | -0.18% | 2.06% | -4% |
| Natural Gas | UNG | 8.7% | 5.4% | 8.3% | -14% |
| Gold | GLD | 10.1% | 10.3% | -25.2% | -54% |
| Silver | SLV | 8% | 1.2% | -23.4% | -36% |
| Copper | CPER | 3.7% | 4.7% | -25.8% | -30% |
VNDA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.2% | 7.1% | -1.3% | -15% |
| iShares High Yield Corp. Bond | HYG | 6.5% | 7.3% | -4.6% | -25% |